{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:18:21Z","timestamp":1758050301445,"version":"3.44.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jcjo.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T19:07:56Z","timestamp":1543000076000},"page":"513-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections"],"prefix":"10.1016","volume":"54","author":[{"given":"Gerardo","family":"Gonzalez-Saldivar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid Yazmin","family":"Pita-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9841-4874","authenticated-orcid":false,"given":"Erick Omar","family":"Flores-Villalobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-0049","authenticated-orcid":false,"given":"Jes\u00fas Noel","family":"Jaurrieta-Hinojos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzel","family":"Espinosa-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geovanni","family":"Rios-Nequis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Ramirez-Estudillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Jimenez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2018.09.006_bib0001","first-page":"707","article-title":"A one-year follow-up study of ocular and systemic complications of intravitreal injection of bevacizumab (Avastin)","volume":"63","author":"Fasih","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0002","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/IAE.0000000000001397","article-title":"Topical apraclonidine reduces pain after intravitreal injections: a double-blind randomized controlled trial","volume":"37","author":"Lagstein","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0003","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00417-014-2837-6","article-title":"Subconjunctival hemorrhage after intravitreal injection of anti-vascular endothelial growth factor","volume":"253","author":"Yun","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0029-1245225","article-title":"Hemorrhagic complications after intravitreal injections of ranibizumab in patients under coumarin-type anticoagulation","volume":"227","author":"Loukopoulos","year":"2010","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jop.1997.13.363","article-title":"Efficacy of oxymetazoline eye drop in non-infectious conjunctivitis, the most common cause of acute red eyes","volume":"13","author":"Xuan","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0006","first-page":"206","article-title":"The application of naphcon eye drops during lasik surgery","volume":"20","author":"Gu","year":"2004","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0007","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jop.1997.13.363","article-title":"Efficacy of oxymetazoline eye drop in non-infectious conjunctivitis, the most common cause of acute red eyes","volume":"13","author":"Xuan","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0008","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/IAE.0b013e3181eef28e","article-title":"Effect of prophylactic topical brimonidine (0.15%) administration on the development of subconjunctival hemorrhage after intravitreal injection","volume":"31","author":"Kim","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2018.09.006_bib0009","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jamaophthalmol.2015.0325","article-title":"Cardiovascular adverse effects of phenylephrine eyedrops: a systematic review and meta-analysis","volume":"133","author":"Stavert","year":"2015","journal-title":"JAMA Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418218307476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418218307476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:07:50Z","timestamp":1757794070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418218307476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0008418218307476"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2018.09.006","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}